Last reviewed · How we verify

Disintegrating placebo tamsulosin tablet

GlaxoSmithKline · Phase 3 active Small molecule

Disintegrating placebo tamsulosin tablet is a Alpha-1A adrenergic receptor antagonist Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 3 development for Benign prostatic hyperplasia with lower urinary tract symptoms.

Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow.

Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow. Used for Benign prostatic hyperplasia with lower urinary tract symptoms.

At a glance

Generic nameDisintegrating placebo tamsulosin tablet
SponsorGlaxoSmithKline
Drug classAlpha-1A adrenergic receptor antagonist
TargetAlpha-1A adrenergic receptor
ModalitySmall molecule
Therapeutic areaUrology
PhasePhase 3

Mechanism of action

Tamsulosin selectively blocks alpha-1A adrenergic receptors located on smooth muscle cells in the prostate and bladder outlet. This receptor antagonism causes smooth muscle relaxation, reducing urethral resistance and improving urine flow rate. The disintegrating tablet formulation is designed for rapid dissolution and absorption to provide faster symptom relief.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Disintegrating placebo tamsulosin tablet

What is Disintegrating placebo tamsulosin tablet?

Disintegrating placebo tamsulosin tablet is a Alpha-1A adrenergic receptor antagonist drug developed by GlaxoSmithKline, indicated for Benign prostatic hyperplasia with lower urinary tract symptoms.

How does Disintegrating placebo tamsulosin tablet work?

Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow.

What is Disintegrating placebo tamsulosin tablet used for?

Disintegrating placebo tamsulosin tablet is indicated for Benign prostatic hyperplasia with lower urinary tract symptoms.

Who makes Disintegrating placebo tamsulosin tablet?

Disintegrating placebo tamsulosin tablet is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

What drug class is Disintegrating placebo tamsulosin tablet in?

Disintegrating placebo tamsulosin tablet belongs to the Alpha-1A adrenergic receptor antagonist class. See all Alpha-1A adrenergic receptor antagonist drugs at /class/alpha-1a-adrenergic-receptor-antagonist.

What development phase is Disintegrating placebo tamsulosin tablet in?

Disintegrating placebo tamsulosin tablet is in Phase 3.

What are the side effects of Disintegrating placebo tamsulosin tablet?

Common side effects of Disintegrating placebo tamsulosin tablet include Retrograde ejaculation, Dizziness, Headache, Asthenia/fatigue, Orthostatic hypotension.

What does Disintegrating placebo tamsulosin tablet target?

Disintegrating placebo tamsulosin tablet targets Alpha-1A adrenergic receptor and is a Alpha-1A adrenergic receptor antagonist.

Related